After taking the vaccines, during first 7 days, the most frequently reported adverse drug reactions in the clinical trial were headache, fever, diarrhea, nausea/vomiting and myalgia and 102 subjects (3.40%) among 2,999 subjects were reported. The incidence rate for children and adults is described on the table as follows. (See Table 1.)

After taking the vaccines, adverse drug reactions were examined for a period of 28 days. 69 subjects (2.30%) among 2,999 subjects were reported with the adverse effects, and gastrointestinal disorders were reported the highest numbers i.e., 35 subjects (1.17%). The adverse drug reactions during the study (28 days) were described on the table as follows.
(Uncommon: 0.1~5%, Rare: less than 0.1%) (See Table 2.)
